Esophageal Squamous Cell Carcinoma (ESCC)
Oncology·MeSH: Esophageal Squamous Cell Carcinoma
3 drugs in development·3 companies·5 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| sugemalimab | EQRx, Inc. (EQRX) |
Phase 2(1)
| Drug | Company |
|---|---|
| Serplulimab | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 1(1)
| Drug | Company |
|---|---|
| tagmokitug | Coherus Oncology, Inc. (CHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Esophageal Squamous Cell Carcinoma (ESCC)?
BioSniper tracks 3 drugs in development for Esophageal Squamous Cell Carcinoma (ESCC) across 3 companies.
How many clinical trials target Esophageal Squamous Cell Carcinoma (ESCC)?
There are 5 clinical trials targeting Esophageal Squamous Cell Carcinoma (ESCC) tracked by BioSniper.
Deep-dive into Esophageal Squamous Cell Carcinoma (ESCC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis